Navigation Links
LSUHSC's Dr. Xiao Cheng Wu co-authors annual report to the nation on cancer
Date:11/25/2008

Xiao Cheng Wu, MD. MPH, Associate Professor and Assistant Director of the Louisiana Tumor Registry at LSU Health Sciences Center New Orleans School of Public Health, co-authored the Annual Report to the Nation on the Status on Cancer, 1975-2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control. The paper reports, for the first time, declines in both cancer incidence and death rates, as well as wide variations in lung cancer trends from state to state. It will be published by the Journal of the National Cancer Institute in the December 2, 2008 issue, available online on November 25, 2008.

Data were drawn from a number of sources including National Cancer Institute designated Surveillance Epidemiology and End Results (SEER) cancer registries, one of which is the Louisiana Tumor Registry at LSU Health Sciences Center New Orleans School of Public Health.

The report, which is a collaboration of the American Cancer Society, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries, reports that both incidence and death rates from all cancers combined are decreasing significantly in men and women overall and in most racial and ethnic populations. These decreases are largely driven by declines in the three most common cancers in men (lung, colorectum, and prostate) and in two of the three leading cancers in women (breast and colorectum), combined with a leveling off of lung cancer death rates in women. Although the national trend in female lung cancer death rates has stabilized since 2003, there is prominent state and regional variation. Lung cancer incidence and/or death rates among women increased in 18 states, 16 of them in the South or Midwest. California was the only state with decreasing lung cancer incidence and death rates in women."Lung cancer is the most frequently diagnosed cancer and leading cause of cancer death in Louisiana," notes Dr. Wu. "Although lung cancer incidenc
'/>"/>

Contact: Leslie Capo
lcapo@lsuhsc.edu
504-452-9166
Louisiana State University Health Sciences Center
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. China Biologic Products Announces Approval for the Relocation of Fang Cheng Plasma Collection Station and for the Procurement of Excess Clinical Plasma
2. Medifast, Inc. Director of Research & Development Co-Authors Health Book
3. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
4. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
5. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
6. Bear Stearns 20th Annual Healthcare Conference to Webcast Millennium Presentation
7. inVentiv Health to Present at the 20th Annual Bear Stearns Healthcare Conference
8. Annual flu shot cuts need for doctors visits, hospitalization among children
9. Edwards Lifesciences to Present at the Bear Stearns 20th Annual Healthcare Conference
10. Johnson & Johnson to Participate in Bear Stearns 20th Annual Healthcare Conference
11. Chem Rx to Present at Bear Stearns 20th Annual Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...over. Every year, almost three million people bec...DS-related diseases." ,, WASHINGTON, Nov. 30 /...he Global AIDS Alliance (GAA) calls on President O...rming reports from the World Health Organization (...e of catastrophic proportion, affecting shockingly...
(Date:11/30/2009)...- Major League Baseball,s Mark Teahen, longtime ...tly acquired by the Chicago White Sox, will receiv... annually to a Major League Baseball player who be...f baseball great Fred Hutchinson, both on and off ...f., native made his MLB debut with the Royals in A...
(Date:11/30/2009)...pact, CBO analysis understates the effect ,, W...e Blue Cross and Blue Shield Association (BCBSA) i...te released today by the Congressional Budget Offi...economists, actuaries, and health policy experts h...ill would make coverage more expensive for million...
(Date:11/30/2009)...,stroke belt, study finds , , MONDAY...stroke belt" of the southern United States have a ...s, even if they live elsewhere later, a new study ...rn in the North and South Carolina, Georgia, Tenne...sistently higher incidence of stroke compared to t...
(Date:11/30/2009)...113 chest X-rays, study finds , , MONDAY...tients who have abdominal/pelvic CT scans receive ...hem to extra radiation, U.S. researchers say. ,...were performed on 500 patients aged 9 months to 91...f age. The researchers concluded that 35.3 percent...
Breaking Medicine News(10 mins):Health News:GAA Calls on President Obama to Act on the Reality of AIDS 2Health News:GAA Calls on President Obama to Act on the Reality of AIDS 3Health News:Mark Teahen Named 2009 Hutch Award Winner 2Health News:CBO Confirms That Premiums Will Increase Under the Senate Healthcare Reform Bill 2Health News:Birth in South Raises Stroke Risk for Life 2Health News:Birth in South Raises Stroke Risk for Life 3Health News:CT Scan Patients May Get Unnecessary Imaging 2
...se of Lords committee report has revealed that abo... babies have not actually been tested on children....ti-epileptic drugs are being prescribed to childre...ard to children. The Medicines and Healthcare Prod...
...rchers belonging to the Oxford University in Engla...ng medication were to manage their own treatment a.../ as many as 2,600 deaths could be avoided. Those ...hich can be reduced by about 40%, when in comparis...
...omeless population among New Yorkers are more pron...her sections of the population. // Detox centers w...hs due to substance abuse are on the rise. Rapid H...in the shelters were accounted for by alcohol, AID...
...tic fluid protects the baby in the mother’s womb. ... of four proteins in the amniotic fluid doctors ca...r whether their infants are at risk of severe infe...e proteins present in the amniotic fluid. These we...
...can President George W. Bush as called for complet...m cell research for cloning and as asked to reduce... in all praise for the change in culture among the...te ban on human reproductive cloning as there six ...
...ort by a House of Lords committee has revealed tha... have never been tested on them. Dangerous drugs l...ven some anti-epileptic drugs are employed in the ...tions like asthma inhalers have also never been tr...
Other Medicine News:
(Date:11/30/2009)..., , NEW YORK, Nov. 30 /PRNewswire/ -...earch report is available in its catalogue: ,, ... http://www.reportlinker.com/p0164299/Surgical-In...al incision closures market holds enormous signifi...being performed each year. Surgical disciplines su...
(Date:11/30/2009)..., , KING OF PRUSSIA, Pa., Nov. 30 /PRNews...nced the completion of a Phase I study of CPSI-236...the production of TNF-alpha and other pro-inflamma...ility dose escalation study in healthy volunteers ...nical testing. ,, All 30 enrolled subjects co...
(Date:11/30/2009)..., , CHICAGO, Nov. 30 MedP...hed ultrasound solutions, will showcase leading ul..., GE Logiq I and Siemens X300 Premium Edition duri...ty of North America (RSNA) conference, being held ...in-based MedPro Imaging markets ultrasound product...
Breaking Medicine Technology:Reportlinker Adds Surgical Incision Closures - Global Trends 2Reportlinker Adds Surgical Incision Closures - Global Trends 3Reportlinker Adds Surgical Incision Closures - Global Trends 4Reportlinker Adds Surgical Incision Closures - Global Trends 5Reportlinker Adds Surgical Incision Closures - Global Trends 6Reportlinker Adds Surgical Incision Closures - Global Trends 7Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 2MedPro Imaging to Showcase Leading New and Refurbished Ultrasound Solutions at RSNA 2Kids of Parents Who Value Exercise Are More Active 50751 1Kids of Parents Who Value Exercise Are More Active 50751 2Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 1Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 2Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 3Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 4Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 5Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 6Lilly Receives Fourth FDA Approval for ALIMTA 28R 29 28pemetrexed for injection 29 50746 7DynaVox Systems LLC Merges with Blink Twice 50741 1DynaVox Systems LLC Merges with Blink Twice 50741 2DynaVox Systems LLC Merges with Blink Twice 50741 3
...sdaq: DCGN ) today announced positive topline res...f DG041, the company,s first-in-class,antagonist o... as a,next-generation oral anti-platelet therapy f...ng bleeding risk. The prospective, randomized,blin...let activation and,bleeding time of DG041 alone an...
...herapeutic Strategy for ...,BioSciences, Inc. (Nasdaq: SGMO ) announced toda... immune system cells (CD4 T-cells) can be made,res...ger DNA-binding,protein nucleases (ZFN(TM)). The d...n the permanent modification of the CCR5 gene enco...
Other Medicine Technology:DG041 Blocks Platelet Aggregation Through a Novel Mechanism and does not Increase Bleeding Time When Given Alone or with Plavix(TM) or Aspirin 2DG041 Blocks Platelet Aggregation Through a Novel Mechanism and does not Increase Bleeding Time When Given Alone or with Plavix(TM) or Aspirin 3DG041 Blocks Platelet Aggregation Through a Novel Mechanism and does not Increase Bleeding Time When Given Alone or with Plavix(TM) or Aspirin 4Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells 2Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells 3Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells 4Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells 5Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells 6
...800 is an individually configurable System for dec...e identification via cap recognition is optional) ... clearly organized workflow. The input and output ...ty. The System can simply be loaded with various t...
...mbination of the Aliquoting System RSD 800A with a... turns out in an efficient System and a complete s...all important front-end and back-end features: cen...ation, sample quality control, decapping, barcode ...
...SD 800A is an individually configurable System for...itional tube type identification via cap recogniti...ample tubes in a clearly organized workflow. The i...ffer high capacity. The System can simply be loade...
...00 can sort different specimen in one run. Complex...more and all samples are sorted, decapped and arch... after being given sorting priorities. Optionally ...a Decapping Module can be integrated. Selectively ...
Medicine Products: